China’s experimental Covid-19 vaccine costs $60

Published October 18, 2020
A Chinese city is offering Sinovac Biotech’s experimental Covid-19 vaccine to essential workers and other high-risk groups as part of a national programme for about $60. —Reuters/File
A Chinese city is offering Sinovac Biotech’s experimental Covid-19 vaccine to essential workers and other high-risk groups as part of a national programme for about $60. —Reuters/File

BEIJING: A Chinese city is offering Sinovac Biotech’s experimental Covid-19 vaccine to essential workers and other high-risk groups as part of a national programme for about $60.

The eastern city of Jiaxing’s center for disease control and prevention (CDC) said in a statement on WeChat that two doses of the vaccine candidate, called CoronaVac, will cost 200 yuan ($29.75) per dose and that vaccinations for key groups including medical professionals have begun.

Chinese authorities have to date not released pricing details for potential Covid-19 vaccines. Hundreds of thousands of people have been given experimental vaccines in late-stage trials as part of an emergency inoculation programme launched in July.

It was not clear if Jiaxing city’s pricing includes subsidies. The city’s CDC declined to comment.

Sinovac did not immediately respond to a request for comment. Its vaccine is in late stage trials in Brazil, Indonesia and Turkey, and the company has said that an interim analysis of Phase three trial data could come as early as November.

Bio Farma, a state-owned firm in Indonesia which has reached a deal for at least 40 million doses from Sinovac, said this week the vaccine will cost around 200,000 rupiah ($13.60) per dose when it becomes available in the southeast Asian country.

China has said that while reasonable profits for companies are permitted, Covid-19 vaccines should be priced close to cost.

China National Pharmaceutical Group (Sinopharm) said in August that a vaccine candidate developed by a unit may cost no more than 1,000 yuan ($148.80) for two shots. An official at China’s National Health Commission has said, however, the price will be lower.

Published in Dawn, October 18th, 2020

Opinion

Coping with Covid perils
01 Aug 2021

Coping with Covid perils

Little accountability in countries such as India and Pakistan has meant whimsical decision-making.
A missing placard
Updated 01 Aug 2021

A missing placard

Scrutiny, protests, and swift police action are no guarantees of justice.
Urban flood risk
01 Aug 2021

Urban flood risk

Flood risk has been exacerbated by unchecked encroachments.
No woman’s land
Updated 31 Jul 2021

No woman’s land

We don’t just have violent men. We have a violent system.

Editorial

Necessary lockdown
Updated 01 Aug 2021

Necessary lockdown

AS the countrywide positivity ratio of Covid-19 infections crossed 8pc, Sindh imposed a nine-day lockdown effective...
01 Aug 2021

No Olympic glory

FOR about 30 minutes at the Tokyo Olympics weightlifting competition last week, Talha Talib remained in the podium...
01 Aug 2021

Preventable E-11 flooding

THE flooding on Wednesday in Islamabad’s E-11/2 sector is deserving of the shock it has spawned. The flouting of...
China-Taliban meeting
Updated 31 Jul 2021

China-Taliban meeting

WITH the government in Kabul appearing to stand on very fragile foundations, and as the clock ticks down to the ...
31 Jul 2021

Outages in Makran

IT is no surprise that people in Balochistan’s Makran Division have of late taken to the streets to protest in the...
31 Jul 2021

Reduction in polio cases

AFTER the long and tedious efforts of those running the national polio programme, there are signs that Pakistan ...